BMedSci, FNS, MB ChB
Clinical Fellow / Academic Junior Doctor
Quantification of Parkinson's Disease
Max is an academic junior doctor interested in neurosurgery, artificial intelligence, space medicine, and rare diseases. He trained in medicine at Bristol (clinical) and Oxford (academic), and is currently working towards DPhil in Clinical Neurosciences. His academic work focuses on objective quantification of neurological disorders, treatment for rare parkinsonian diseases and the use of AI in clinical practice. He’s been recognised for several clinical, academic and teaching achievements, including National Clinical Neurosciences Award, Harvey Cushing Gold Medal, BGS and Wellcome Trust scholarships.
He is interested in adapting research solutions in a practical, clinical way, be it in pioneering neurosurgery, head injury, or expedition medicine. He delivered lectures, tutorials and public presentations in several countries, always gripping his audiences’ attention with dark humour, dynamic expression, and active gesticulation.
Max is a member of Neurometrology lab, which is a multidisciplinary team of academics and clinicians working on better symptom and disease progression solutions. He also takes a keen interest in public engagement, working with the team to deliver Art in Neuroscience events and participants-researchers meetings.
In his policy work, he focuses on consulting and shaping national guidelines for neurosurgical and psychiatric care. He is the youngest president ever elected to be a President of the Oxford Neurological Society, working on raising awareness of non-obvious symptoms of diseases, like cognition or mental health.
He was a University of Oxford Medical School DGH Tutor of the Year in 2020 (Student choice).
Neuroscience is not all about a shaking arm or a spastic muscle. Behind every Parkinson's disease, there is a unique and infinitely interesting person, who experiences a wide range of symptoms in their very own, inimitable way.
Sometimes the intricate function of the brain goes wrong. My research is aiming to find where that fault is and how to fix it. I want to produce better ways of assessing Parkinsonian diseases, looking behind the scenes to appreciate the whole picture: track down the disorder in movement, cognition, memory, and executive function.
As a clinician, I want to be able to offer my patients a better, more objective and accurate way of quantifying the disease. As a scientist, I want to help advance our knowledge of parkinsonism and shape the future of the research in this field.
Our group achieves that by inviting the participants to perform a battery of physical, memory, and eye movement exercises. The data output is then analysed to work out patterns, correlations, and new methods of assessment.
I believe we can use the recent developments in computational neurology, artificial intelligence and bioinformatics to achieve our aims quicker and more efficiently. I am passionate about implementing our findings to enhance the patient’s experience and improve the neurological practice right at the frontline of the health service.
Licence to Practice
UK (GMC 7672217)
Iceland (Læknanúmer 2863 Kt 021193-5859)
OTHER RESEARCH INTERESTS
How to Manage Head Injury With COVID-19 Pneumonitis On Mars? Rare But High Impact Complex Medical Emergencies In Space.
MA Brzezicki, DC Crockett, A Cooney, JM Strachan
(2020) Journal of Surgical Research
Artificial Intelligence Outperforms Human Students In Conducting Neurosurgical Audits
MA Brzezicki, NE Bridger, MD Kobetić, et al., S Neumann
(2020) Clinical Neurology and Neurosurgery
The Influence of Deep Brain Stimulation on Eye Movements
S Patell, MA Brzezicki, JF FitzGerald, CA Antoniades
(2019) Advances in Translational Neuroscience of Eye Movement Disorders
Five Reasons Why Generalised Anxiety Disorder Should Be A Metabolic Disease
MA Brzezicki, M Ostrowski, M Carr, NE Bridger
(2019) Oxford Metabolic Health
Prolonged unconsciousness in perampanel overdose
G Parsons, J Bailey, F Bailey, MA Brzezicki
(2019) BMJ Case Reports
Diagnostic accuracy of frontotemporal dementia. An artificial intelligence- powered study of symptoms, imaging and clinical judgement
MA Brzezicki, MD Kobetić, S Neumann, C Pennington
(2019) International Journal of Surgery 43, 56-57
Rare Presentation of a Relapsing Remitting Central Nervous System Vasculitis: A Case Report
MA Brzezicki, MD Kobetić, S Dillon
(2019)Fortschritte der Neurologie - Psychiatire, 87(02):129-132
Efficient Treatment for Complex Regional Pain Syndrome: A Critical Review.
MA Brzezicki, PT Zakowicz, A Chodorowska
Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives
MA Brzezicki, MD Kobetic
(2018) Neurology and Therapy, 1-3